INmune Bio, Inc. (INMB)
1.505
+0.04
(+2.38%)
USD |
NASDAQ |
Jan 13, 16:00
1.505
0.00 (0.00%)
After-Hours: 20:00
INmune Bio Market Cap: 40.01M for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.634B |
| Palatin Technologies, Inc. | 15.79M |
| Theriva Biologics, Inc. | 7.035M |
| Oragenics, Inc. | 0.7296M |
| NanoViricides, Inc. | 21.60M |
Market Cap Related Metrics
| PS Ratio | 712.32 |
| Price to Book Value | 1.577 |
| Price | 1.505 |
| Earnings Yield | -142.2% |